Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP)
达罗鲁胺联合雄激素剥夺疗法治疗高危生化复发的前列腺癌(ARASTEP)
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2577633
Morgans, Alicia K; Chehrazi-Raffle, Alex; Niazi, Tamim; Shore, Neal D; Ross, Ashley E; Røder, Andreas; Gomes, Andrea Juliana; Supiot, Stephane; Barthélémy, Philippe; Hatano, Koji; Ruiz, Carmen Belen Congregado; Yoshida, Soichiro; Herrera-Imbroda, Bernardo; Gratton, Matthieu; Gschwend, Jürgen E; Hope, Thomas A; Joensuu, Heikki; Kuss, Iris; Le Berre, Marie-Aude; Dimova-Dobreva, Miryana; Fizazi, Karim